Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Mischa Reis Biography and Net Worth

SVP of Envista

As SVP Strategy & Corporate Development, Mischa Reis leads Envista’s strategic planning and mergers and acquisitions (M&A) activities, including portfolio management, market analysis, deal sourcing, valuation, due diligence, negotiation, and deal execution.

Mischa joined Danaher in 2012 as VP Business Development and Strategy for the Dental Platform, with responsibility for driving its strategy and inorganic growth activities. During his tenure, he completed more than 10 deals spanning four continents, ranging from small minority investments in innovative startups to the $2B+ acquisition of Nobel Biocare.

Prior to Danaher, Mischa worked at Fortune 500 company Avery Dennison for 10 years in a variety of business development, marketing, and strategy roles, most recently as VP and Head of Corporate Strategy. He started his career as a consultant at The Boston Consulting Group in Frankfurt, Germany.

Mischa holds a master’s degree equivalent in Business Administration & Industrial Engineering from the Karlsruhe Institute of Technology, Germany. He lives in Los Angeles, California, with his wife and three kids and is a passionate soccer player (and even more passionate soccer fan of his hometown team, Bayern Munich).

What is Mischa Reis' net worth?: The estimated net worth of Mischa Reis is at least $994,916.52 as of August 27th, 2021. Mr. Reis owns 49,059 shares of Envista stock worth more than $994,917 as of April 25th. This net worth estimate does not reflect any other investments that Mr. Reis may own. Learn More about Mischa Reis' net worth.
How old is Mischa Reis?: Mr. Reis is currently 51 years old. There are 4 older executives and no younger executives at Envista. The oldest executive at Envista is Mr. Amir Aghdaei, President, CEO & Director, who is 65 years old. Learn More on Mischa Reis' age.
How do I contact Mischa Reis?: The corporate mailing address for Mr. Reis and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]. Learn More on Mischa Reis' contact information.
Has Mischa Reis been buying or selling shares of Envista?: Mischa Reis has not been actively trading shares of Envista during the last ninety days. Most recently, Mischa Reis sold 2,958 shares of the business's stock in a transaction on Tuesday, March 1st. The shares were sold at an average price of $47.83, for a transaction totalling $141,481.14. Learn More on Mischa Reis' trading history.
Who are Envista's active insiders?: Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Eric Conley (SVP), Jeffrey Kappler (SVP), Stephen Keller (Principal Financial Officer), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO). Learn More on Envista's active insiders.
Are insiders buying or selling shares of Envista?: During the last twelve months, Envista insiders bought shares 4 times. They purchased a total of 19,185 shares worth more than $417,124.65. The most recent insider tranaction occured on November, 16th when SVP Eric Conley bought 2,185 shares worth more than $50,014.65. Insiders at Envista own 1.3% of the company. Learn More about insider trades at Envista.
Information on this page was last updated on 11/16/2023.

Mischa Reis Insider Trading History at Envista

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/1/2022	Sell	2,958	$47.83	$141,481.14
2/25/2022	Sell	5,009	$47.59	$238,378.31
2/11/2022	Sell	6,056	$47.50	$287,660.00
12/23/2021	Sell	10,016	$45.00	$450,720.00
8/27/2021	Sell	10,016	$42.50	$425,680.00	49,059
5/3/2021	Sell	1,049	$43.73	$45,872.77	49,159
9/20/2019	Buy	1,000	$22.00	$22,000.00

Mischa Reis Buying and Selling Activity at Envista

Envista Company Overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Today's Range

Now: $20.08

$19.92

$20.21

50 Day Range

MA: $21.05

$19.16

$22.87

2 Week Range

Now: $20.08

$18.95

$38.68

Volume

95,681 shs

Average Volume

2,295,092 shs

Market Capitalization

$3.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad